Clearside Biomedical Inc (CLSD) — Cash Flow-to-Debt Ratio
Clearside Biomedical Inc (CLSD) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of $-5.48 Million could theoretically repay 0% of its total liabilities ($65.59 Million) in one year. See CLSD cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearside Biomedical Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Clearside Biomedical Inc across 13 annual periods. Also explore net asset momentum of Clearside Biomedical Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Clearside Biomedical Inc (2012–2024)
Year-by-year debt coverage analysis for Clearside Biomedical Inc. For market capitalisation and broader financial context, see CLSD company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.39x | $-24.70 Million | $63.98 Million | ▼ -6.3% |
| 2023 | -0.36x | $-18.14 Million | $49.93 Million | ▼ -10.6% |
| 2022 | -0.33x | $-13.37 Million | $40.70 Million | ▲ +84.9% |
| 2021 | -2.18x | $-10.73 Million | $4.93 Million | ▼ -75.3% |
| 2020 | -1.24x | $-13.12 Million | $10.56 Million | ▲ +28.3% |
| 2019 | -1.73x | $-27.07 Million | $15.62 Million | ▲ +55.1% |
| 2018 | -3.86x | $-79.20 Million | $20.50 Million | ▼ -44.3% |
| 2017 | -2.68x | $-51.08 Million | $19.08 Million | ▼ -55.1% |
| 2016 | -1.73x | $-22.71 Million | $13.15 Million | ▼ -616.7% |
| 2015 | -0.24x | $-13.90 Million | $57.71 Million | ▲ +22.1% |
| 2014 | -0.31x | $-9.12 Million | $29.51 Million | ▲ +41.8% |
| 2013 | -0.53x | $-6.84 Million | $12.88 Million | ▲ +88.1% |
| 2012 | -4.48x | $-3.18 Million | $709.00K | — |